NS
Neovacs S.A.
🇫🇷XPAR.ALNEVFranceHealthcare
€0.25EURdown -0.01 (-3.85%)ClosedEnd of day5:13 PM
Price€0.25-0.01 (-3.85%)
Profile
- Healthcare
- Biotechnology
- France
Identity
- Exchange
- Euronext Paris . XPAR
- Type
- Stock
- ISIN
- FR00140077X1
- CUSIP
- Not reported
Company
- Employees
- 20
- Headquarters
- Paris, France
- Website
- https://www.neovacs.com
Market
- Shares outstanding
- 476.6K
- Market cap
- €119.16K
Highlights
- Market cap
- €123.92K
- EPS LTM
- -€1.18
- P/E LTM
- -69,922,201.67
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €1.11K-95.07%down year on year
- Net income
- -€3.55M+70.02%up year on year
- Gross margin
- -563,037.68%-2,694.71%down year on year
- Free cash flow
- -€4.6M+55.14%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.